Wenjin Wang Selected Research

Carcinogenesis

1/2022	Overexpression of PTPRZ1 Regulates p120/β-Catenin Phosphorylation to Promote Carcinogenesis of Oral Submucous Fibrosis.
1/2021	N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma.
1/2021	TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6.
1/2021	N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenjin Wang Research Topics

Disease

7	Ulcerative Colitis 01/2022 - 09/2019
4	Carcinogenesis 01/2022 - 01/2021
4	Neoplasms (Cancer) 01/2022 - 01/2021
4	Opioid-Induced Constipation 11/2011 - 11/2009
3	Oral Submucous Fibrosis 01/2022 - 09/2017
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2021
3	Crohn Disease (Crohn's Disease) 01/2019 - 09/2014
3	Pain (Aches) 08/2011 - 11/2009
3	Gastroesophageal Reflux (GERD) 02/2011 - 10/2006
2	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2021
2	Necrosis 01/2022 - 09/2019
2	Wounds and Injuries (Trauma) 01/2021 - 01/2019
2	Fibrosis (Cirrhosis) 11/2020 - 09/2017
2	Cicatrix (Scar) 01/2019 - 10/2018
2	Constipation 01/2011 - 11/2009
1	Trigeminal Nerve Injuries 01/2022
1	Dementia (Dementias) 10/2021
1	Hypertension (High Blood Pressure) 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	COVID-19 08/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Psoriatic Arthritis 01/2021
1	Rheumatoid Arthritis 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Dehydration (Water Stress) 12/2020
1	Congenital Abnormalities (Deformity) 08/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2019
1	Hepatic Encephalopathy 01/2019
1	Neuroma 10/2018
1	Autoimmune Diseases (Autoimmune Disease) 09/2017
1	Bone Resorption 10/2015
1	Inflammation (Inflammations) 10/2015
1	Pathologic Constriction (Stenosis) 09/2015
1	Esophageal Stenosis (Esophageal Stricture) 09/2015
1	Stomach Neoplasms (Stomach Cancer) 10/2014
1	Hypercholesterolemia 10/2014
1	Breast Neoplasms (Breast Cancer) 06/2013
1	Muscle Cramp (Cramp) 11/2011
1	Abdominal Pain (Pain, Abdominal) 11/2011
1	Esophagitis 09/2010
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2009
1	Infections 12/2003
1	Peptic Ulcer (Peptic Ulcers) 12/2003
1	Ulcer 01/2002

Drug/Important Bio-Agent (IBA)

8	tofacitinibIBA 01/2022 - 09/2014
7	Janus Kinase InhibitorsIBA 01/2022 - 09/2014
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2017
4	methylnaltrexone FDA Link 11/2011 - 11/2009
4	Pantoprazole (Protonix)FDA LinkGeneric 02/2011 - 12/2003
3	Pharmaceutical PreparationsIBA 01/2022 - 09/2019
3	Biological ProductsIBA 01/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
2	CateninsIBA 01/2022 - 01/2021
2	Creatine Kinase (Creatine Phosphokinase)IBA 09/2021 - 01/2021
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	N-methyladenosineIBA 01/2021 - 01/2021
2	CollagenIBA 01/2019 - 09/2017
2	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2011 - 11/2009
2	Opioid Analgesics (Opioids)IBA 01/2011 - 11/2009
2	Metronidazole (Metric)FDA LinkGeneric 12/2003 - 01/2002
2	Amoxicillin (Wymox)FDA LinkGeneric 12/2003 - 01/2002
2	Clarithromycin (Biaxin)FDA LinkGeneric 12/2003 - 01/2002
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	SolutionsIBA 08/2021
1	HydrogelsIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	ElectrolytesIBA 12/2020
1	Arecoline (Arecolin)IBA 04/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2019
1	NeurotoxinsIBA 08/2019
1	Rifaximin (L 105)FDA Link 01/2019
1	Lactulose (Duphalac)FDA LinkGeneric 01/2019
1	3-hydroxyphenyltrimethylammoniumIBA 09/2017
1	AutoantibodiesIBA 09/2017
1	AutoantigensIBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	CytokinesIBA 10/2015
1	LigandsIBA 10/2015
1	SteroidsIBA 09/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014
1	Estrogen ReceptorsIBA 06/2013
1	SuspensionsIBA 09/2010
1	LaxativesIBA 11/2009
1	UreaseIBA 12/2003

Therapy/Procedure

4	Therapeutics 09/2019 - 12/2003
1	Oral Surgery (Maxillofacial Surgery) 01/2022
1	Nerve Transfer 01/2022
1	Aftercare (After-Treatment) 11/2021
1	Drug Tapering 07/2021
1	Radiotherapy 01/2021
1	Sutures (Suture) 10/2018
1	Analgesia 11/2009